A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2019
Price : $35 *
At a glance
- Drugs Palbociclib (Primary) ; Anastrozole; Exemestane; Fulvestrant; Letrozole; Tamoxifen
- Indications Advanced breast cancer; Bone metastases; Carcinoma
- Focus Therapeutic Use
- Acronyms ASPIRE
- 25 Jun 2019 Planned End Date changed from 30 Jun 2020 to 30 Jun 2021.
- 25 Jun 2019 Planned primary completion date changed from 30 Jun 2020 to 30 Jun 2021.
- 06 Jun 2019 Planned End Date changed from 31 Mar 2020 to 30 Jun 2020.